A variety of therapeutic options are now available for advanced renal cell cancer, including antiangiogenic and anti-mTOR agents. Allogeneic hematopoietic stem cell transplantation, through its graft-versus-tumor effect, can induce clinical responses and prolonged survival in selected cytokine-refractory patients. However, the still relevant transplant-related mortality due to toxicity and graft-versus-host disease is an obstacle to its widespread use. © Ivyspring International Publisher.

Allogeneic stem cell transplantation for metastatic renal cell cancer (RCC) / Bregni, M.; Ciceri, F.; Peccatori, J.. - In: JOURNAL OF CANCER. - ISSN 1837-9664. - 2:1(2011), pp. 347-349. [10.7150/jca.2.347]

Allogeneic stem cell transplantation for metastatic renal cell cancer (RCC)

Ciceri F.
Secondo
;
2011-01-01

Abstract

A variety of therapeutic options are now available for advanced renal cell cancer, including antiangiogenic and anti-mTOR agents. Allogeneic hematopoietic stem cell transplantation, through its graft-versus-tumor effect, can induce clinical responses and prolonged survival in selected cytokine-refractory patients. However, the still relevant transplant-related mortality due to toxicity and graft-versus-host disease is an obstacle to its widespread use. © Ivyspring International Publisher.
2011
Advanced renal cell cancer
Allogeneic hematopoietic stem cell transplantation
Graft-versus-tumor
File in questo prodotto:
File Dimensione Formato  
v02p0347.pdf

accesso aperto

Tipologia: PDF editoriale (versione pubblicata dall'editore)
Licenza: Creative commons
Dimensione 349.14 kB
Formato Adobe PDF
349.14 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/138382
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact